Your browser doesn't support javascript.
loading
Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
Rooney, Claire; Geh, Catherine; Williams, Victoria; Heuckmann, Johannes M; Menon, Roopika; Schneider, Petra; Al-Kadhimi, Katherine; Dymond, Michael; Smith, Neil R; Baker, Dawn; French, Tim; Smith, Paul D; Harrington, Elizabeth A; Barrett, J Carl; Kilgour, Elaine.
Afiliação
  • Rooney C; AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
  • Geh C; AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
  • Williams V; AstraZeneca, Personalised Healthcare and Biomarkers Innovative Medicines, Alderley Park, Macclesfield and Melbourn, Cambridge, United Kingdom.
  • Heuckmann JM; Blackfield AG, Cologne, Germany.
  • Menon R; Blackfield AG, Cologne, Germany.
  • Schneider P; Blackfield AG, Cologne, Germany.
  • Al-Kadhimi K; AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
  • Dymond M; AstraZeneca, Discovery Sciences Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
  • Smith NR; AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
  • Baker D; AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
  • French T; AstraZeneca, Personalised Healthcare and Biomarkers Innovative Medicines, Alderley Park, Macclesfield and Melbourn, Cambridge, United Kingdom.
  • Smith PD; AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
  • Harrington EA; AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
  • Barrett JC; AstraZeneca Oncology Innovative Medicines, Gatehouse Park, Waltham, Massachusetts, United States of America.
  • Kilgour E; AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom.
PLoS One ; 11(2): e0149628, 2016.
Article em En | MEDLINE | ID: mdl-26905262

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Pirazóis / Benzamidas / Carcinoma Pulmonar de Células não Pequenas / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Terapia de Alvo Molecular / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Pirazóis / Benzamidas / Carcinoma Pulmonar de Células não Pequenas / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Terapia de Alvo Molecular / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article